Klemens Rappersberger

Austrian Competence Centre of Food Safety

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Suppression of NRAS-mutant melanoma growth with NRAS-targeting Antisense Oligonucleotide treatment reveals therapeutically relevant kinase co-dependencies”.

Suppression of NRAS-mutant melanoma growth with NRAS-targeting Antisense Oligonucleotide treatment reveals therapeutically relevant kinase co-dependencies

Communications Medicine(2025)10.1038/s43856-025-00932-5

N/A

0.208DataRank · unranked

3 citations

Yixuan James Zheng, Tiange Qu, Dasha Hohlova, Ciara Callanan, Li-Nan Chen +12 more

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment

Oncotarget(2023)10.18632/oncotarget.28447

N/A

0DataRank · unranked

28 citations

Yixuan James Zheng, Wilson Ho, Li-Nan Chen, Ciara Callanan, Christopher S. Chen +5 more

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

Research Square(2023)10.21203/rs.3.rs-1297358/v3

N/A

0DataRank · unranked

1 citations

Li-Nan Chen, Yixuan James Zheng, Wilson Ho, Martina Sanlorenzo, Igor Vujic +21 more

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cell survival in NRAS/MAPK-driven melanoma

Research Square(2023)10.21203/rs.3.rs-1297358/v2

N/A

0DataRank · unranked

0 citations

Li-Nan Chen, Yixuan James Zheng, Wilson Ho, Martina Sanlorenzo, Igor Vujic +21 more

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

Molecular Cancer(2024)10.1186/s12943-024-01955-7

N/A

0DataRank · unranked

15 citations

Li-Nan Chen, Yixuan James Zheng, Wilson Ho, Martina Sanlorenzo, Igor Vujic +21 more